Regulating gene data; U.S. and E.U. may implement restrictions on patent rights and statutues to protect privacy
Article Abstract:
Differences between the United States and the European Union in the patentability of human genome technology are discussed. US patent law realizes that the commercial rewards of patent protection help to recoup the biotechnology industry's large investments in research and also ensure the public disclosure of innovations. The 1998 European Union Directive on the Legal Protection of Biotechnological Innovations expresses uncertainty over permitting the commercial exploitation of human genome technology.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
What's left to patent? The PTO's written-description requirements limit the scope of genome-related inventions
Article Abstract:
Issues are discussed regarding obtaining patents for genome-related inventions and for the medical and other products to be obtained from genes derived from nonhuman species. The Patent and Trademark Office rules for obtaining patents on genes are also discussed at some length.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Patent law; gene sequences
Article Abstract:
Standards to be used in the potential patentability of new gene sequences are discussed. Only gene sequences with utility will meet the utility requirements for genome patentability. Initial genome mapping discoveries may lead to uses in several fields.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: IRS announces new position on FICA tax for employer stock acquired under s. 423 employee stock purchase plans
- Abstracts: In-house IP lawyers may lose key job; some say patent lawyers lack biz savvy to manage key assets. Big times for small IP firms; there is so much work, they're getting big firms' clients
- Abstracts: LSC down but not out; with reauthorizations stalling, ABA carries on fight for legal services. Good numbers; new federal budget adds up for ABA-supported programs
- Abstracts: Is extrinsic evidence ever necessary to resolve claim construction disputes? Is extrinsic evidence ever necessary to decide claim construction disputes?
- Abstracts: Buckeye's best; top litigators include counsel for mass tort plaintiffs and a pioneer in false claims suits. Earth shakers; here are 10 of the state's top litigators, representing plaintiffs and defendants